Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.
Lupin, Aurobindo get USFDA nod for HIV drug - Zee News
Zee NewsLupin, Aurobindo get USFDA nod for HIV drugZee NewsSimilarly, Hyderabad-headquartered Aurobindo Pharma also said it has received approval from the USFDA for generic Lamivudine and Zidovudine tablets of the same strength.
Aurobindo gets USFDA nod for anti-HIV drugs - Hindu Business Line
Aurobindo gets USFDA nod for anti-HIV drugsHindu Business LineAurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Lamivudine and Zidovudine tablets.
South Africa exceeds 2007-11 treatment targets by 50% - aidsmap
South Africa exceeds 2007-11 treatment targets by 50%aidsmapCrude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently.